Document is current
Any future updates will be listed below
-
Authors
Wu, Qing https://orcid.org/0000-0002-6629-270X
Yi, Zhengfei
Li, Haoran
Han, Guoxin
Du, Jianyong
Xiong, Jingwei https://orcid.org/0000-0001-8438-4782
Hu, Keping https://orcid.org/0000-0003-3580-2233
-
Funding
Funding for this research was provided by:
Chinese Academy of Medical Sciences (3332022048)
State Administration of Traditional Chinese Medicine of the People's Republic of China (ZYYCXTD-C-202210)
- License Information
-
More Information
Article History
Received: 25 March 2024
Accepted: 1 October 2024
First Online: 12 October 2024
Competing interests
: The authors declare the following competing interests: Qing Wu and Keping Hu have been listed as inventors on three patent applications related to the content of this work, which are currently pending. These include: (1) the application of the CRISPR-Cas13a system in DNA detection (CN patent app. 202311768005.4), (2) Cas12a mutants and their applications (CN patent app. 202311790309.0), and (3) Cas12f1 mutants and their applications (CN patent app. 202311790565.X), all filed by the Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences.
